Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan
NCT01323998
·
clinicaltrials.gov ↗
COMPLETED
Status
35032
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
5ARI
DRUG:
AB
Sponsor
GlaxoSmithKline